Summary
- Current Price
- As of today, NVCT price is $8.76, down -0.45% on
- Current Price All-Time High
- NVCT price is currently -58.13% below its historical high of $20.92 set on
- Market Cap
- NVCT current market cap is $224M, up +42.85% over the past 365 days
- PE Ratio
- NVCT PE ratio is unknown
- Revenue
- NVCT current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for NVCT is on
Profile
| Metric | Value |
|---|---|
| Full Name | Nuvectis Pharma, Inc. |
| Ticker | NASDAQ: NVCT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | nuvectis.com |
| Employees | 13 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $8.76 | ||
| Price, 1D Change | -0.45% | |
| $224M | ||
| - | ||
| - | ||
| 0.84 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.32 | ||
| EPS, 1Y Change | -19.21% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.32 | ||
| EPS Estimate | N/A | -$1.27 |
| EPS Est. Change | N/A | +4.35% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $8.76 | ||
| Price Target | - | $18.00 |
| Price Tgt. Change | - | +105.48% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.01 | -$1.11 | -10.29% | |
| -$1.31 | -$1.32 | -0.88% | |
| -$1.27 | N/A | +4.35% | |
| -$1.32 | N/A | +0.57% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +26.04% | ||
| -26.08% | ||
| +42.85% | ||
| +29.32% | ||
| 0.00% | ||
| 0.00% | ||
| -19.21% | ||
| +12.22% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $8.76 | ||
| $7.45 | ||
| SMA 200 vs Price | -14.95% | |
| $8.10 | ||
| SMA 50 vs Price | -7.53% | |
| 0.84 | ||
| $0.49 | ||
| 56.26 | ||
| 38.34% | ||
| 68.72% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.32 | ||
| $0.00 | ||
| - | ||
| -$27.57M | ||
| - | ||
| -$28.87M | ||
| - | ||
| -$27.57M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 2.38 | ||
| 2.38 | ||
| - | ||
| - | ||
| 3.55 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 12.19 | ||
| -6.99 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $18.41M | ||
| $31.63M | ||
| $31.71M | ||
| $31.71M | ||
| $13.30M | ||
| $13.30M | ||
| $0.00 | ||
| $0.00 | ||
| $6.27M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $28.87M | ||
| $27.57M | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$16.01M | ||
| $0.00 | ||
| $29.11M | ||
| $0.00 | ||
| -$16.01M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Maxim Group | ||
| Laidlaw & Co. | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | ||
| HC Wainwright & Co. |
Analyst sentiment
Institutional ownership
Screeners with NVCT
FAQ
What is the ticker symbol for Nuvectis Pharma, Inc.?
The ticker symbol for Nuvectis Pharma, Inc. is NASDAQ:NVCT
Does Nuvectis Pharma, Inc. pay dividends?
No, Nuvectis Pharma, Inc. does not pay dividends
What sector is Nuvectis Pharma, Inc. in?
Nuvectis Pharma, Inc. is in the Healthcare sector
What industry is Nuvectis Pharma, Inc. in?
Nuvectis Pharma, Inc. is in the Biotechnology industry
What country is Nuvectis Pharma, Inc. based in?
Nuvectis Pharma, Inc. is headquartered in United States
When did Nuvectis Pharma, Inc. go public?
Nuvectis Pharma, Inc. initial public offering (IPO) was on February 4, 2022
Is Nuvectis Pharma, Inc. in the S&P 500?
No, Nuvectis Pharma, Inc. is not included in the S&P 500 index
Is Nuvectis Pharma, Inc. in the NASDAQ 100?
No, Nuvectis Pharma, Inc. is not included in the NASDAQ 100 index
Is Nuvectis Pharma, Inc. in the Dow Jones?
No, Nuvectis Pharma, Inc. is not included in the Dow Jones index
When was Nuvectis Pharma, Inc. last earnings report?
Nuvectis Pharma, Inc.'s most recent earnings report was on February 11, 2026
When does Nuvectis Pharma, Inc. report earnings?
The next expected earnings date for Nuvectis Pharma, Inc. is May 5, 2026
Data Sources & References
- NVCT Official Website www.nuvectis.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1875558/000110465926013044/0001104659-26-013044-index.htm
- NVCT Profile on Yahoo Finance finance.yahoo.com/quote/NVCT
- NVCT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvct